Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estimating the conditional false-positive rate for semi-latent data.

Lize van der Merwe1, J Stephan Maritz

  • 1Department of Statistics and Actuarial Science, Stellenbosch University, P.O. Box 19070, Tygerberg 7505, South Africa. lvdm@sun.ac.za

Epidemiology (Cambridge, Mass.)
|July 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variation in neuropeptide Y interacts with childhood trauma to influence anxiety sensitivity.

Anxiety, stress, and coping·2021
Same author

Antenatal Uterotonics as a Risk Factor for Intrapartum Stillbirth and First-day Death in Haryana, India: A Nested Case-control Study.

Epidemiology (Cambridge, Mass.)·2020
Same author

Telacebec (Q203), a New Antituberculosis Agent.

The New England journal of medicine·2020
Same author

Optimizing β-Lactams against Tuberculosis.

American journal of respiratory and critical care medicine·2020
Same author

Liquid mycobacterial culture outcomes after different sputum collection techniques before and during treatment.

Tuberculosis (Edinburgh, Scotland)·2019
Same author

The evaluation of anti-tuberculosis drug effects on phenotypes of Mycobacterium tuberculosis not detected by culture methods.

Tuberculosis (Edinburgh, Scotland)·2019
Same journal

Application of the E-value under non-proportional hazards.

Epidemiology (Cambridge, Mass.)·2026
Same journal

Can the All of Us sample be reweighted to mirror a nationally representative sample? A comparison of mortality predictors.

Epidemiology (Cambridge, Mass.)·2026
Same journal

Gut health, systemic inflammation, and linear growth among Indonesian infants: findings from the Action Against Stunting Hub observation cohort: Erratum.

Epidemiology (Cambridge, Mass.)·2026
Same journal

Evaluating Estimators in Partially Identified Models.

Epidemiology (Cambridge, Mass.)·2026
Same journal

Stratification and accumulation? Explaining changing mortality inequities between business owners and non-owners in the U.S. (1984-2022).

Epidemiology (Cambridge, Mass.)·2026
Same journal

Be wary of age-stratum aging in early-onset cancer trends.

Epidemiology (Cambridge, Mass.)·2026
See all related articles

This study introduces a novel Bayesian model to estimate disease test accuracy when the gold standard is unavailable for all participants. The new method accurately assesses test sensitivity and specificity even with incomplete gold standard data.

Area of Science:

  • Biostatistics
  • Medical Diagnostics
  • Epidemiology

Background:

  • Accurate disease testing requires knowing true disease status.
  • Gold standard confirmation is often limited to positive test results.
  • This creates a data gap for negative test results.

Purpose of the Study:

  • To develop a statistical model for estimating test sensitivity and specificity.
  • To address situations where gold standard data is semi-latent (unavailable for negatives).
  • To compare two diagnostic tests without full gold standard data.

Main Methods:

  • A Bayesian approach is used for parameter estimation.
  • The model estimates sensitivity and specificity.
  • It accounts for non-independent error rates between tests.

Related Experiment Videos

Main Results:

  • The model provides estimates for test performance parameters.
  • It derives specificity conditional on false-positive results.
  • This allows for more robust test comparisons with incomplete data.

Conclusions:

  • The proposed Bayesian model effectively estimates diagnostic test accuracy.
  • It is suitable for semi-latent gold standard data scenarios.
  • This enhances the ability to compare disease detection tests.